A patient is admitted to the inpatient alcohol rehabilitation program. What medication will the patient most likely be prescribed to treat alcohol withdrawal syndromes?
A) Clonidine (Catapres)
B) Methyldopa (Aldomet)
C) Chlordiazepoxide (Librium)
D) Atenolol (Tenormin)
C
Feedback:
Benzodiazepines antianxiety agents are the drugs of choice for treating alcohol withdrawal syndromes. Chlordiazepoxide is administered to patients for acute withdrawal syndrome. Clonidine is not a benzodiazepine and is not prescribed for acute alcohol syndrome. Methyldopa is not a benzodiazepine and is not prescribed for acute alcohol syndrome. Atenolol is not a benzodiazepine and is not prescribed for acute alcohol syndrome.
You might also like to view...
When calculating the rate to administer heparin solutions, D represents a flow rate: units/time
Indicate whether the statement is true or false
The nurse is implementing evidence-based practice. Which of the following is not a component of this process?
1. Patient preference 2. Clinical expertise 3. Research evidence 4. Leader practice
You have been called to an apartment for a child who is sick. As you approach the 4-year-old boy, you note that he is sitting upright in his mother arms with his chin thrust forward. He has a very lethargic and sickly appearance and is drooling. His airway appears open and his breathing is adequate. His radial pulse is strong and his skin is hot to the touch. Which of the following interventions would be most appropriate in the care of this patient?
a. Placing the boy supine for transport b. Suctioning secretions from the back of the airway c. Placement of an oropharyngeal airway d. Provision of blow-by oxygen
A child who has congenital hypothyroidism takes levothyroxine 75 mcg/day. The child weighs 15 kg. The primary care NP sees the child for a 3-year-old check-up. The NP should consult with a pediatric endocrinologist to discuss:
a. increasing the dose to 90 mcg/day. b. decreasing the dose to 30 mcg/day. c. stopping the medication and checking TSH and T4 in 4 weeks. d. discussing the need for lifetime replacement therapy with the child's parents.